{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:41:30Z","timestamp":1789940490883,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T00:00:00Z","timestamp":1438128000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Michel B\u00e9langer PhD Scholarship from the Institut de Recherches Cliniques de Montr\u00e9al"},{"DOI":"10.13039\/100000897","name":"Canadian Cystic Fibrosis Foundation","doi-asserted-by":"crossref","award":["18608"],"award-info":[{"award-number":["18608"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Banting and Best scholarship from the Canadian Institutes of Health Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00592-015-0791-3","type":"journal-article","created":{"date-parts":[[2015,7,27]],"date-time":"2015-07-27T21:54:27Z","timestamp":1438034067000},"page":"359-366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis"],"prefix":"10.1007","volume":"53","author":[{"given":"Ad\u00e8le","family":"Coriati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Ziai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Lavoie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Berthiaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Rabasa-Lhoret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,29]]},"reference":[{"key":"791_CR1","unstructured":"Canada CF (2012) Canadian Cystic Fibrosis Registry. 2012 Annual Report. http:\/\/www.cysticfibrosis.ca\/wp-content\/uploads\/2014\/03\/Canadian-CF-Registry-English-FINAL-FOR-WEB1.pdf"},{"issue":"127","key":"791_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1183\/09059180.00008112","volume":"22","author":"JS Elborn","year":"2013","unstructured":"Elborn JS (2013) Personalised medicine for cystic fibrosis: treating the basic defect. Eur Respir Rev 22(127):3\u20135. doi: 10.1183\/09059180.00008112","journal-title":"Eur Respir Rev"},{"issue":"4","key":"791_CR3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.rmed.2008.10.011","volume":"103","author":"NJ Simmonds","year":"2009","unstructured":"Simmonds NJ, Cullinan P, Hodson ME (2009) Growing old with cystic fibrosis\u2014the characteristics of long-term survivors of cystic fibrosis. Respir Med 103(4):629\u2013635. doi: 10.1016\/j.rmed.2008.10.011","journal-title":"Respir Med"},{"issue":"12","key":"791_CR4","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2337\/dc10-1279","volume":"33","author":"A Moran","year":"2010","unstructured":"Moran A, Becker D, Casella SJ, Gottlieb PA, Kirkman MS, Marshall BC, Slovis B, Committee CCC (2010) Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review. Diabetes Care 33(12):2677\u20132683. doi: 10.2337\/dc10-1279","journal-title":"Diabetes Care"},{"issue":"6","key":"791_CR5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jcf.2007.02.005","volume":"6","author":"M Costa","year":"2007","unstructured":"Costa M, Potvin S, Hammana I, Malet A, Berthiaume Y, Jeanneret A, Lavoie A, Levesque R, Perrier J, Poisson D, Karelis AD, Chiasson JL, Rabasa-Lhoret R (2007) Increased glucose excursion in cystic fibrosis and its association with a worse clinical status. J Cyst Fibros 6(6):376\u2013383. doi: 10.1016\/j.jcf.2007.02.005","journal-title":"J Cyst Fibros"},{"key":"791_CR6","author":"JC Burgess","year":"2015","unstructured":"Burgess JC, Bridges N, Banya W, Gyi KM, Hodson ME, Bilton D, Simmonds NJ (2015) HbA1c as a screening tool for cystic fibrosis related diabetes. J Cyst Fibros. doi: 10.1016\/j.jcf.2015.03.013","journal-title":"J Cyst Fibros"},{"issue":"12","key":"791_CR7","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","volume":"33","author":"A Moran","year":"2010","unstructured":"Moran A, Brunzell C, Cohen RC, Katz M, Marshall BC, Onady G, Robinson KA, Sabadosa KA, Stecenko A, Slovis B, Committee CG (2010) Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care 33(12):2697\u20132708. doi: 10.2337\/dc10-1768","journal-title":"Diabetes Care"},{"issue":"5","key":"791_CR8","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2012-3971","volume":"98","author":"C Bianchi","year":"2013","unstructured":"Bianchi C, Miccoli R, Trombetta M, Giorgino F, Frontoni S, Faloia E, Marchesini G, Dolci MA, Cavalot F, Cavallo G, Leonetti F, Bonadonna RC, Del Prato S, Investigators G (2013) Elevated 1-h postload plasma glucose levels identify subjects with normal glucose tolerance but impaired beta-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study. J Clin Endocrinol Metab 98(5):2100\u20132105. doi: 10.1210\/jc.2012-3971","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"791_CR9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00592-012-0384-3","volume":"49","author":"M Manco","year":"2012","unstructured":"Manco M, Miraglia Del Giudice E, Spreghini MR, Cappa M, Perrone L, Brufani C, Rustico C, Morino G, Caprio S (2012) 1-Hour plasma glucose in obese youth. Acta Diabetol 49(6):435\u2013443. doi: 10.1007\/s00592-012-0384-3","journal-title":"Acta Diabetol"},{"issue":"suppl 1","key":"791_CR10","first-page":"S212","volume":"37","author":"CDACPGE","year":"2013","unstructured":"CDACPGE (2013) Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 37(suppl 1):S212","journal-title":"Can J Diabetes"},{"issue":"2","key":"791_CR11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/dc10-1604","volume":"34","author":"J Brodsky","year":"2011","unstructured":"Brodsky J, Dougherty S, Makani R, Rubenstein RC, Kelly A (2011) Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis. Diabetes Care 34(2):292\u2013295. doi: 10.2337\/dc10-1604","journal-title":"Diabetes Care"},{"issue":"10","key":"791_CR12","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc09-0585","volume":"32","author":"A Moran","year":"2009","unstructured":"Moran A, Pekow P, Grover P, Zorn M, Slovis B, Pilewski J, Tullis E, Liou TG, Allen H, Cystic Fibrosis Related Diabetes Therapy Study G (2009) Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial. Diabetes Care 32(10):1783\u20131788. doi: 10.2337\/dc09-0585","journal-title":"Diabetes Care"},{"issue":"1","key":"791_CR13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcf.2013.06.001","volume":"13","author":"K Schmid","year":"2014","unstructured":"Schmid K, Fink K, Holl RW, Hebestreit H, Ballmann M (2014) Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test. J Cyst Fibros 13(1):80\u201385. doi: 10.1016\/j.jcf.2013.06.001","journal-title":"J Cyst Fibros"},{"issue":"3","key":"791_CR14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.diabet.2007.01.004","volume":"33","author":"I Hammana","year":"2007","unstructured":"Hammana I, Malet A, Costa M, Brochiero E, Berthiaume Y, Potvin S, Chiasson JL, Coderre L, Rabasa-Lhoret R (2007) Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis. Diabetes Metab 33(3):213\u2013219. doi: 10.1016\/j.diabet.2007.01.004","journal-title":"Diabetes Metab"},{"issue":"4","key":"791_CR15","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2337\/diacare.24.4.796","volume":"24","author":"M Stumvoll","year":"2001","unstructured":"Stumvoll M, Van Haeften T, Fritsche A, Gerich J (2001) Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 24(4):796\u2013797","journal-title":"Diabetes Care"},{"issue":"2","key":"791_CR16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jcf.2010.11.004","volume":"10","author":"S Ziai","year":"2011","unstructured":"Ziai S, Belson L, Hammana I, Berthiaume Y, Rabasa-Lhoret R (2011) Validation of insulin secretion indices in cystic fibrosis. J Cyst Fibros 10(2):145. doi: 10.1016\/j.jcf.2010.11.004","journal-title":"J Cyst Fibros"},{"issue":"8","key":"791_CR17","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2337\/dc08-0225","volume":"31","author":"MA Abdul-Ghani","year":"2008","unstructured":"Abdul-Ghani MA, Abdul-Ghani T, Ali N, Defronzo RA (2008) One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 31(8):1650\u20131655. doi: 10.2337\/dc08-0225","journal-title":"Diabetes Care"},{"issue":"2","key":"791_CR18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2337\/dc09-1342","volume":"33","author":"G Bardini","year":"2010","unstructured":"Bardini G, Dicembrini I, Cresci B, Rotella CM (2010) Inflammation markers and metabolic characteristics of subjects with 1-h plasma glucose levels. Diabetes Care 33(2):411\u2013413. doi: 10.2337\/dc09-1342","journal-title":"Diabetes Care"},{"issue":"19","key":"791_CR19","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","volume":"358","author":"BE Metzger","year":"2008","unstructured":"Group HSCR, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA (2008) Hyperglycemia and adverse pregnancy outcomes. N Eng J Med 358(19):1991\u20132002. doi: 10.1056\/NEJMoa0707943","journal-title":"N Eng J Med"},{"issue":"6","key":"791_CR20","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2337\/dc12-1861","volume":"36","author":"JY Kim","year":"2013","unstructured":"Kim JY, Goran MI, Toledo-Corral CM, Weigensberg MJ, Choi M, Shaibi GQ (2013) One-hour glucose during an oral glucose challenge prospectively predicts beta-cell deterioration and prediabetes in obese Hispanic youth. Diabetes Care 36(6):1681\u20131686","journal-title":"Diabetes Care"},{"issue":"2","key":"791_CR21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/dc09-1492","volume":"33","author":"S Hameed","year":"2010","unstructured":"Hameed S, Morton JR, Jaffe A, Field PI, Belessis Y, Yoong T, Katz T, Verge CF (2010) Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain. Diabetes Care 33(2):221\u2013226. doi: 10.2337\/dc09-1492","journal-title":"Diabetes Care"},{"issue":"2","key":"791_CR22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcf.2006.03.009","volume":"6","author":"AL Brennan","year":"2007","unstructured":"Brennan AL, Gyi KM, Wood DM, Johnson J, Holliman R, Baines DL, Philips BJ, Geddes DM, Hodson ME, Baker EH (2007) Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. J Cyst Fibros 6(2):101\u2013109. doi: 10.1016\/j.jcf.2006.03.009","journal-title":"J Cyst Fibros"},{"issue":"5","key":"791_CR23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jcf.2008.01.004","volume":"7","author":"T Ntimbane","year":"2008","unstructured":"Ntimbane T, Krishnamoorthy P, Huot C, Legault L, Jacob SV, Brunet S, Levy E, Gueraud F, Lands LC, Comte B (2008) Oxidative stress and cystic fibrosis-related diabetes: a pilot study in children. J Cyst Fibros 7(5):373\u2013384. doi: 10.1016\/j.jcf.2008.01.004","journal-title":"J Cyst Fibros"},{"issue":"9","key":"791_CR24","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2337\/diacare.28.9.2141","volume":"28","author":"CE Milla","year":"2005","unstructured":"Milla CE, Billings J, Moran A (2005) Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 28(9):2141\u20132144","journal-title":"Diabetes Care"},{"issue":"2","key":"791_CR25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/ajcn.81.2.421","volume":"81","author":"M Rafii","year":"2005","unstructured":"Rafii M, Chapman K, Stewart C, Kelly E, Hanna A, Wilson DC, Tullis E, Pencharz PB (2005) Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis. Am J Clin Nutr 81(2):421\u2013426","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"791_CR26","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jcf.2009.08.007","volume":"8","author":"I Hammana","year":"2009","unstructured":"Hammana I, Potvin S, Tardif A, Berthiaume Y, Coderre L, Rabasa-Lhoret R (2009) Validation of insulin secretion indices in cystic fibrosis patients. J Cyst Fibros 8(6):378\u2013381. doi: 10.1016\/j.jcf.2009.08.007","journal-title":"J Cyst Fibros"},{"issue":"2","key":"791_CR27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.diabet.2013.02.001","volume":"39","author":"L Monnier","year":"2013","unstructured":"Monnier L, Hanefeld M, Schnell O, Colette C, Owens D (2013) Insulin and atherosclerosis: How are they related? Diabetes Metab 39(2):111\u2013117. doi: 10.1016\/j.diabet.2013.02.001","journal-title":"Diabetes Metab"},{"issue":"5","key":"791_CR28","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1210\/jc.2013-2756","volume":"99","author":"A Coriati","year":"2014","unstructured":"Coriati A, Belson L, Ziai S, Haberer E, Gauthier MS, Mailhot G, Coderre L, Berthiaume Y, Rabasa-Lhoret R (2014) Impact of sex on insulin secretion in cystic fibrosis. J Clin Endocrinol Metab 99(5):1767\u20131773. doi: 10.1210\/jc.2013-2756","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"791_CR29","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1139\/apnm-2013-0022","volume":"38","author":"A Coriati","year":"2013","unstructured":"Coriati A, Elisha B, Virassamynaik S, Phaneuf M, Ziai S, Gauthier MS, Rabasa-Lhoret R (2013) Diagnosis of cystic fibrosis-related glucose abnormalities: can we shorten the standard oral glucose tolerance test? Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme 38(12):1254\u20131259. doi: 10.1139\/apnm-2013-0022","journal-title":"Physiologie appliquee, nutrition et metabolisme"},{"key":"791_CR30","author":"A Coriati","year":"2015","unstructured":"Coriati A, Ziai S, Azar M, Berthiaume Y, Rabasa-Lhoret R (2015) Characterization of patients with cystic fibrosis presenting an indeterminate glucose tolerance (INDET). J Cyst Fibros. doi: 10.1016\/j.jcf.2015.03.001","journal-title":"J Cyst Fibros"},{"issue":"11","key":"791_CR31","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.2337\/dc12-0459","volume":"35","author":"E Mozzillo","year":"2012","unstructured":"Mozzillo E, Raia V, Fattorusso V, Falco M, Sepe A, De Gregorio F, Nugnes R, Valerio G, Franzese A (2012) Glucose derangements in very young children with cystic fibrosis and pancreatic insufficiency. Diabetes Care 35(11):e78","journal-title":"Diabetes Care"},{"key":"791_CR32","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00592-015-0743-y","volume":"52","author":"A Franzese","year":"2015","unstructured":"Franzese A, Mozzillo E, Fattorusso V, Raia V, Valerio G (2015) Screening of glucose metabolism derangements in pediatric cystic fibrosis patients: how, when, why. Acta Diabetol 52:633\u2013638. doi: 10.1007\/s00592-015-0743-y","journal-title":"Acta Diabetol"},{"issue":"3","key":"791_CR33","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1399-5448.2008.00451.x","volume":"10","author":"E Mozzillo","year":"2009","unstructured":"Mozzillo E, Franzese A, Valerio G, Sepe A, De Simone I, Mazzarella G, Ferri P, Raia V (2009) One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements. Pediatric Diabetes 10(3):162\u2013167","journal-title":"Pediatric Diabetes"},{"issue":"4","key":"791_CR34","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/EJE-14-0644","volume":"172","author":"R Barrio","year":"2015","unstructured":"Barrio R (2015) Management of endocrine disease: cystic fibrosis-related diabetes: novel pathogenic insights opening new therapeutic avenues. Eur J Endocrinol 172(4):R131\u2013R141. doi: 10.1530\/EJE-14-0644","journal-title":"Eur J Endocrinol"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-015-0791-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-015-0791-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-015-0791-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T16:07:43Z","timestamp":1567008463000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-015-0791-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,29]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["791"],"URL":"https:\/\/doi.org\/10.1007\/s00592-015-0791-3","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,29]]}}}